HATFIELD, England, May 28, 2012 /PRNewswire/ -- CHMP also issues positive opinion for monotherapy use of Eisais Zonegran(R) (zonisamide) Eisai announced today that the European Medicines Agencys Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa(R) (perampanel) as an adjunctive treatment of focal seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older. Perampanel has a different mechanism of action to current antiepileptic drugs (AEDs). As an AMPA receptor antagonist, perampanel is the first of a new class of AED.[1] The neurotransmitter glutamate plays a major role in the mediating seizures and perampanel is the only agent that selectively targets the transmission of seizures by blocking post synaptic glutamate AMPA receptors.[2,3] AMPA receptors are currently not selectively targeted by any other available AED.[2,3,4] Based on todays recommendation, EU approval of the new therapy is anticipated within three months. In addition to the CHMP recommendation for the use of perampanel as an adjunctive treatment, Eisai received a positive CHMP opinion for Zonegran(R) (zonisamide) as monotherapy for the treatment of partial seizures (with or without secondary generalisation) in adults with newly diagnosed epilepsy. Zonisamide is a second … Continue reading →

27-05-2012 09:27 Special upload for webkinzgirle12 and turebeliever24 I DO NOT OWN THIS SHOW S05E14 Selective Breeding Lu treats a young patient with Bi-Polar disease which causes her to act hazardously violent. Her mother must decide whether to keep her or give her up to a mental institution. Meanwhile, Andy helps a woman have an invitro fertilization. She uses new technology to help the couple have a boy because of a genetic female-only disease in the family but later a web of lies and deceivements is revealed. Peter gets jealous when Kayla dates a man he volunteers for at a zoo. Go here to read the rest: Strong Medicine ''Selective Breeding'' 1/2 - Video … Continue reading →

Washington: A growing number of Americans are travelling to India to seek treatment for rare diseases through India's experimental embryonic stem cell therapy, according to an investigative report. Among them Cash Burnaman, a 6-year-old South Carolina boy, who travelled with his parents to India seeking treatment for a rare genetic condition that has left him developmentally disabled, CNN reported. "Cash is mute. He walks with the aid of braces. To battle his incurable condition, which is so rare it doesn't have a name, Cash has had to take an artificial growth hormone for most of his life," it said. A growing number of Americans are travelling to India to seek treatment for rare diseases through experimental embryonic stem cell therapy. His divorced parents, Josh Burnaman and Stephanie Krolick, have paid tens of thousands of dollars to have Cash undergo experimental injections of human embryonic stem cells at New Delhi's NuTech Mediworld run by Dr Geeta Shroff, a retired obstetrician and self-taught embryonic stem cell practitioner. Shroff first treated Cash -- who presents symptoms similar to Down Syndrome -- in 2010. "I am helping improve their quality of life," she told CNN. After five weeks of treatment, Cash and his parents … Continue reading →